ASH 2015 Updates: Practice-Changing Abstracts

Chicago, IL US
March 5, 2016

Patients in medically underserved communities have limited access to subspecialty care. Community-based oncologists are well positioned to provide initial care for these patients, but often do not have the knowledge and confidence to manage difficult cases. Between 2006 and 2008, the City of Chicago experienced an annual average adjusted cancer mortality rate of 194.2 deaths per 100,000 population. City of Chicago cancer mortality rates are higher than the regional, statewide and nationwide cancer death rates. This conference with updates from th 58th ASH Annual Meeting & Exposition addresses early treatment options and medical advances that can be implemented in an effort to reduce cancer-related deaths. Our goal is to join community-based providers and academic oncologists to reach our Health People 2020 target of 160.0 cancer related deaths per 100,000 population or lower.


Target Audience

This activity has been planned for medical oncologists, hematology oncologists, and other health care professionals committed to reducing cancer-related deaths.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Describe recent scientific developments in the care of patients with hematologic disorders;
  • Evaluate patients with early stage hematologic malignancies;
  • Explain how to administer the appropriate frontline therapeutics for the treatment of blood diseases;
  • State the referral criteria for patients to receive advanced treatment of hematologic malignancies from a specialist;
  • List the treatment options and clinical trials in the area of hematologic disorders available to patients.




Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Aaron Chrisman
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Participation
Event starts: 
03/05/2016 - 8:00am
Event ends: 
03/05/2016 - 12:35pm
Activity opens: 
Activity expires: 
Gleacher Center
450 N Cityfront Plaza
Chicago, IL 60611
United States

Michael R. Bishop, MD

Professor of Medicine
Director, Hematopoietic Stem Cell Transplantation Program

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses and other healthcare professionals will receive a Certificate of Participation.  For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board. 


To register, click the button below:



Please login or create an account to proceed.